Cardiff Oncology (CRDF) Other Working Capital Changes (2016 - 2025)

Cardiff Oncology has reported Other Working Capital Changes for 8 years, with the latest figure at -$178000.0 in Q4 2025.

• Quarterly Other Working Capital Changes fell 9.2% year-over-year to -$178000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$691000.0 (down 10.38% YoY) and the FY2025 annual result came in at -$691000.0, down 10.38% from the prior year.
• Other Working Capital Changes slipped to -$178000.0 in Q4 2025 per CRDF's latest filing, from -$175000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $1.2 million in Q4 2022 and troughed at -$1.2 million in Q4 2024.
• A 5-year average of $7578.9 and a median of -$3000.0 in 2022 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes jumped 92.95% in 2022, then sank 762.5% in 2023.
• Over 5 years, Other Working Capital Changes stood at -$166000.0 in 2021, then grew by 19.88% to -$133000.0 in 2022, then fell by 9.77% to -$146000.0 in 2023, then fell by 11.64% to -$163000.0 in 2024, then fell by 9.2% to -$178000.0 in 2025.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$178000.0, -$175000.0, and -$171000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.